News & Events

We thank Dr Jennifer Rayner (Optometrist) for sharing her expertise and knowledge with us!

You can download the “Best Practice” for FREE and read why Dr Rayner says: “A tool such as the OCULUS Keratograph 5M with specific JENVIS Pro Dry Eye Report software allows for advanced testing to understand the subtleties and complex nature of the ocular surface and tear-film.”

The Belin ABCD Progression Display as part of the OCULUS Pentacam® software is establishing itself as an indispensable clinical standard which is demonstrated by an ongoing output of studies.

There are new studies which show the many benefits:
• Dubinsky-Pertzov et al on the benefits of using the Belin ABCD Progression Display for children
• Vinciguerra et al report superiority of the Belin ABCD Progression Display over Kmax
• Flockerzi et al highlight the significance of posterior corneal surface assessment in KC
• Balparda et al focus on the Belin ABCD Progression Display for assessing the Quality of Life

The new GRAS (Gullstrand Refractive Analysis System) software module of the Myopia Master® is a great advance for any myopia manager, but also for eye refractive analysis in general.
The new GRAS Module also provides an ideal basis for your consultations: The Myopia Master® is the only device that differentiates between the refractive components of the cornea, crystalline lens and axis length in relation to the Gullstrand eye model, enabling you to provide the very best in patient education. The lucid displays will give flanking support to your verbal explanations. This is especially an asset when communicating with parents.

OCULUS course at the CXL Experts’ Meeting 2020 Virtual Meeting, Friday, 17th December 17:15 h CET.


Thank you to our fantastic faculty Prof Michael Belin, Prof Farhad Hafezi and Prof Perthold Seitz & Dr Elias Flockerzi for lecturing on
"Keratoconus: Monitoring the Disease with Pentacam® and Corvis® ST"
We look forward to exciting talks! Register here

The brand-new BEST Display is now available for the Corvis® ST. Biomechanical assessment before refractive surgery has been essential since the introduction of the Tomographic Biomechanical Index. The new software includes novel features that open up the field for further clinical applications.

It enables you to analyze keratoconus progression, related to a baseline measurement. In addition, it can detect early sings of improvement after corneal crosslinking. Whereas topographic changes only occur after several months biomechanical changes can be measured with the Corvis® ST already four weeks after the procedure.

The BEST Display is the ideal solution for detecting and monitoring biomechanical changes over time. Please contact your local distributor if you want to get this new software.

At the end of December this year, the company Antonio Moutinho, Lda., will end its activity in the field of ophthalmology. For over 40 years, OCULUS has been represented in Portugal by the very company. We are extremely grateful to Mr. José Ribeiro and his team for this long-term partnership and we wish them all the best! Obrigado!

As of 1st October 2021, we will start a new partnership with the company Optometron, which will offer the main range of OCULUS diagnostic equipment on an exclusive basis in Portugal. From this date visit www.optometron.pt and contact the team for information on OCULUS instruments.
Welcome to the OCULUS family!

OCULUS has joined the International Myopia Institute (IMI) in tackling myopia awareness and will support the IMI activities to advance the research of myopia to prevent future vision impairment and blindness.

Christian Kirchhübel, CEO of OCULUS announces: “We are delighted about the cooperation. Our mission at OCULUS is to support eye care professionals around the world with cutting-edge, high-tech development. We are dedicated to saving and improving vision and visual performance with our precise, reliable long-lasting measurement solutions.”

The IMI is a global group of experts who have come together to discuss, debate and make available the latest evidence-based recommendations in classifications, patient management, and research, in the form of the IMI white papers, in up to twelve international languages.